Opus Point Partners Management’s Ligand Pharmaceuticals LGND Stock Holding History

Opus Point Partners Management’s Portfolio LGND Stock Details LGND Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$242K	Buy
2019 Q2	$241K	Buy
2019 Q1	$219K	Buy
2017 Q4	–	Sell
2017 Q3	$207K	Sell
2017 Q2	$257K	Sell
2017 Q1	$394K	Buy
2016 Q4	$263K	Buy